TechFinancials on MSN
Apirone’s 2025 year in review: growth, innovation & powerful new features
As 2025 comes to a close, Apirone has reached one of its most transformative years yet. Throughout the year, the team focused ...
Based Detection, Linguistic Biomarkers, Machine Learning, Explainable AI, Cognitive Decline Monitoring Share and Cite: de Filippis, R. and Al Foysal, A. (2025) Early Alzheimer’s Disease Detection from ...
Abbott has announced the company has received approval from the U.S. Food and Drug Administration (FDA) for its Volt PFA ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback